#China #biopharmaceuticals #Yantai #GMP Certification #CelluPro

CelluPro Achieves EXCiPACT™ Certification for GMP-Grade Cell Culture Media Manufacturing

In a significant advancement for the biopharmaceutical sector, CelluPro, a prominent biotechnology firm known for its innovative serum-free cell culture media and bioprocessing solutions, has recently received the prestigious EXCiPACT™ GMP certification. This makes CelluPro the first company in China to achieve this important recognition for its pharmaceutical auxiliary materials, positioning it at the forefront of the global biomanufacturing landscape.

What is EXCiPACT™ Certification?

The EXCiPACT™ certification is internationally recognized for ensuring Good Manufacturing Practice (GMP) in the production of pharmaceutical excipients, which are critical auxiliary materials used in biopharmaceutical manufacturing. By adhering to these rigorous standards, CelluPro can demonstrate its commitment to quality management, effective manufacturing controls, transparent traceability, and reliable supply chain practices.

This certification serves as an assurance to partners and clients that CelluPro's products meet essential quality and regulatory requirements. The recognition empowers the firm to operate confidently in an increasingly competitive market where the integrity and efficacy of biopharmaceutical products are paramount.

Underpinning Quality with Global Standards

CelluPro has fortified its internal quality system through compliance with various international standards, including ISO 9001, ISO 13485, ISO 14001, ISO 45001, and ISO 22301. By encompassing quality management, environmental management, occupational health and safety, and business continuity within its operational framework, CelluPro demonstrates its resolve to maintain exceptional quality and sustainable practices in serving its global biopharmaceutical partners.

The rising demand for effective cell culture media across diverse biopharmaceutical development pipelines necessitates such robust quality systems. As research transitions from preliminary studies to clinical and commercial manufacturing stages, CelluPro's expertise and certification empower it to provide stable and reliable media that fulfill rigorous quality and regulatory standards at every level of production.

A Wide Range of Applications

CelluPro boasts a decade's worth of experience in formulating cell culture media tailored for various biopharmaceutical applications. The company's manufacturing platform is capable of producing cell culture media suitable for a myriad of processes, from research and development through to clinical and mass-production activities. Noteworthy applications include CHO-based recombinant protein production, HEK293 cell line-based protein and viral vector production, as well as advancements in cell and gene therapies.

The firm has already facilitated three commercial manufacturing projects in collaboration with major multinational pharmaceutical companies. Moreover, CelluPro's contributions extend to supporting products that have successfully undergone FDA Biologics License Application (BLA) and European Medicines Agency (EMA) evaluations, affording it rich experience in navigating complex biopharmaceutical regulations.

Strengthening Global Supply Chains

As the biopharmaceutical industry diversifies its process development and manufacturing requirements, CelluPro is committed to expanding its manufacturing capacity and international supply capabilities. This commitment serves to provide biopharmaceutical manufacturers access to GMP-grade cell culture media, thus ensuring greater global sourcing flexibility and reliability. By enhancing its operations, CelluPro is poised to meet the evolving needs of year-round biopharmaceutical innovation and ensure that its partners are equipped for current market demands.

In summary, CelluPro's achievement of EXCiPACT™ GMP certification is a notable milestone that solidifies its position as a leader in the biotechnology sector. With an unwavering focus on quality, efficiency, and innovation, the company stands ready to support the next generation of biopharmaceutical products and processes with confidence and expertise. For more information about CelluPro's GMP-grade cell culture media solutions, visit www.cellupro.com.